A cost-effectiveness analysis of strategies for controlling Japanese encephalitis in Andhra Pradesh, India

Journal of Pharmaceutical Finance, Economics and Policy

Volumn 15, Issue 1, 2006, Pages 21-40

  Suraratdecha, Chutima ^a   Jacobson, Julie ^b   Sivalenka, Srilatha ^a   Narahari, Dhanwada ^a  

^a PATH ^*

^b PATH   (United States)

Author keywords

Cost effectiveness; Immunization strategies; Japanese encephalitis; SA 14 14 2; Vaccine

Indexed keywords

BELLADONNA 200; BELLADONNA ALKALOID; CALCAREA CARB 200; INACTIVATED VACCINE; LIVE VACCINE; TUBERCULINUM 10M;

COST CONTROL; COST EFFECTIVENESS ANALYSIS; EPIDEMIC ENCEPHALITIS; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; INDIA; INFECTION CONTROL; PRIORITY JOURNAL; REVIEW; VACCINATION;

EID: 33747102730     PISSN: 15385698     EISSN: 15385396     Source Type: Journal    
DOI: 10.1300/J371v15n01_05     Document Type: Review

References (32)

1. Ao J, Yu YX, Tang YS, et al. 1983. Selection of a better immunogenic and highly attenuated live-vaccine strain of Japanese encephalitis: Safety and immunogenicity of live JE vaccine SA 14-14-2 observed in inoculated children. Chinese Journal of Microbiology and Immunology. 3(4):246-248.
2. Ding D, Kilgore PE, Clemens JD, et al. 2003. Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China. Bulletin of the World Health Organization. 81(5):334-342.
3. Halstead SB, Tsai TF. 2004. Japanese encephalitis vaccines. In: Vaccines, 4th ed. Edited by Plotkin SA, Orenstein WA, 919-958. Philadelphia, PA: WB Saunders.
4. Hennessy S, Liu Z, Tsai TF, et al. 1996. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA 14-14-2): a case-control study. Lancet. 358(9284):791-795.
5. Hoke CH, Nisalak A, Sangawipha N, et al. 1988. Protection against Japanese encephalitis by inactivated vaccines. New England Journal of Medicine. 319:608-614.
6. Hsu TC, Chow LP, Wei HY, et al. 1971. A controlled field trial for an evaluation of the effectiveness of mouse-brain Japanese encephalitis vaccine. Journal of Formosa Medical Association. 70:55-61.
7. Hsu TC, Chow LP, Wei HY, et al. 1972. A completed field trial for an evaluation of the effectiveness of mouse-brain Japanese encephalitis vaccine. In Immunization for Japanese encephalitis, ed. Hammon W, Kitapka M, Downs WG, 285-291. Amsterdam: Excerpta Medica.
8. Kamala CS, et al. 1989. Japanese encephalitis in children in Bellary, Karnataka. Indian Pediatrician. 26(5):445-452.
9. Kumar R, et al. 1993. Clinical sequelae of Japanese encephalitis in children. Indian Journal of Medical Research. 97:9-13.
10. Lopez AD, Salomon J, Ahmad O, et al. 2001. Life Tables for 191 Countries: Data, Methods, and Results. Global Programme on Evidence for Health Policy Discussion Paper Series: No. 9. Geneva: World Health Organization.
11. Luo D, et al. 1994. The efficacy of Japanese encephalitis vaccine in Henan, China: a case control study. Southeast Asian Journal of Tropical Medicine and Public Health. 25(4):643-646.
12. Luo D, Song J, Ying H, et al. 1995. Prognostic factors of early sequelae and fatal outcome of Japanese encephalitis. Southeast Asian Journal of Tropical Medicine and Public Health. 26:694-698.
13. Mohan Rao CV, Risbud AR, et al. 1993. Serological response to Japanese encephalitis vaccine in a group of school children in South Arcot district of Tamil Nadu. Indian Journal of Medical Research. 97:53-59.
14. Murray CJL, Lopez AD. 1996. Global Disease Burden of Disease. Vol. 2, The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Boston: Harvard University Press.
15. Nargarjuna M, Roa PV, Veerabhadraiah, et al. 2000. Atlas of Incidence of Japanese Encephalitis in Andhra Pradesh. Strategic Planning Cell, Andhra Pradesh Vaidya Vidhana Parishad, Hyderabad.
16. Ohrr H, Tandan JB, Sohn YM, et al. 2005. Effect of single dose of SA 14-14-2 vaccine 1 year after immunization in Nepalese children with Japanese encephalitis: a case-control study. Lancet. 366(9494):1375-1378.
17. Rao LN, Saxena SN. 1989. Vaccine against Japanese encephalitis. Journal of Communicable Diseases. (21):75-80.
18. Rao LN et al. 1988. Safety and efficacy of Japanese encephalitis vaccine produced in India. Indian Journal of Medical Research. 88:301-307.
19. Rao PN. 2003. Japanese Encephalitis. 35th ed. Hyderabad: Farah Printers.
20. Rosen L. 1986.The natural history of Japanese encephalitis virus. Annual Review of Microbiology. 40:395-414.
21. Service MW. 1991. Agricultural development and arthropod-borne disease - a review. Revista de Saude Publica. 25:165-178.
22. Siraprapasiri T, Sawaddiwudhipong W, Rojanasuphot S. 1997. Cost benefit analysis of Japanese encephalitis vaccination program in Thailand. Southeast Asian Journal of Tropical Medicine and Public Health. 28(1):143-148.
23. Sringernyuang L, Chunsuttiwat S. 2004. Policy Assessment of Thailand's Japanese Encephalitis Immunization. Bangkok, Thailand: Mahidol University.
24. Sucharit S, Surathin K, Shrestha SR. 1989. Vectors of Japanese encephalitis virus (JEV): species complexes of the vectors. Southeast Asian Journal of Tropical Medicine and Public Health. 20(4):611-621.
25. Takahashi H, Pool V, Tsai F, Chen RT. 2000. Adverse events after Japanese encephalitis vaccination. Vaccine. 18:2963-2969.
26. Thongcharoen P. 1989. Japanese encephalitis virus: an overview. Southeast Asian Journal of Tropical Medicine and Public Health. 20:559-753.
27. Wang JL, Na JQ, Zhao SS, et al. 1993. An epidemiology study on the efficacy of Japanese encephalitis live vaccine. Chinese Journal of Biology. 36-37. In Chinese.
28. World Health Organization, The Commission on Macroeconomics and Health. 2001. Macroeconomics and Health: Investing in Health for Economic Development. Geneva: World Health Organization.
29. Wu YC, et al. 1999. The epidemiology of Japanese encephalitis on Taiwan during 1992-1994. American Journal of Tropical Medicine and Hygiene. 69(9):505-510.
30. Yu YX, Zhang GM, Guo YP, et al. 1987. Selection of a better immunogenic and highly attenuated live-vaccine strain of Japanese encephalitis. Chinese Journal of Microbiology and Immunology. 8(2):84-86. In Chinese.
31. Zhou BL, Jia LL, Xu XL, et al. 1999. A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA 14-14-2) in the JE endemic areas. Chinese Journal of Epidemiology. 20(1): 38-41. In Chinese.
32. Zhou BL, Zhang M, Chen PQ, et al. 2001. An 11-year follow-up of epidemiological effect of Japanese encephalitis vaccine, live (SA 14-14-2). China Journal of Biologicals. 14(3): 1-5. In Chinese.